Van Lanschot Kempen Logo
  • Home
  • Solutions
  • News & knowledge
  • About us
Apr 2013
Joint Bookrunner
€ 53.9 million
Accelerated Bookbuild Offering


Galapagos is a Belgian biotech company listed on Euronext Brussels and Euronext Amsterdam

  • Galapagos placed 2,696,831 shares (10% of outstanding shares) in the accelerated bookbuild offering
  • Participating investors were mainly located in the US, and predominantly included specialist healthcare investors
  • Kempen acted as Joint Bookrunner, combining supply and demand in order not to put unnecessary pressure on the share price

Fully focused on your future

Private Banking

  • Offices
  • Business professionals
  • Executives
  • Doctors
  • Entrepreneurs
  • Wealth management
  • Conditions
  • Private Banking - Belgium
  • Private Banking - Switzerland

Professional Solutions

Investment Management

Investment Banking

© Van Lanschot Kempen 2023
Privacy & cookies